Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns ...

Second-generation antipsychotics appeared to curb COVID-19 infection in those with serious mental illness, a retrospective study showed. Looking at adults hospitalized long-term in the New York ...

High doses of a second-generation antipsychotic are associated with a significantly increased risk for death in young adults, adding to long-standing safety concerns regarding the use of higher doses ...

Oct. 25, 2005 (Amsterdam) — Although all of the atypical antipsychotic agents preserve neurocognitive function, they vary in terms of the specific domains they influence, said Richard S. E. Keefe, PhD ...

Treatment of anorexia nervosa in adolescents is often difficult due to the ego-syntonic nature of some of its expressions, such as strict dieting, excessive exercising, and low weight. Indeed, ...

What Is Bysanti, and Why Does It Matter? Bysanti (milsaperidone) is a new FDA-approved oral medicine for treating certain mental health conditions in adults. It belongs to a group of medicines called ...

Bristol Myers Squibb (NYSE: BMY) today announced data from a Phase 4 clinical trial evaluating the symptom stability, safety and tolerability of Cobenfy (xanomeline and trospium chloride) when ...

Credit: Getty Images. Helping patients and family members navigate behavioral and psychologic symptoms of dementia is a large part of providing care to people living with dementia. Dementia is an ...

Vanda Pharmaceuticals Inc. gained U.S. FDA approval for Bysanti (milsaperidone), cleared for use in acute bipolar I disorder and schizophrenia and ensuring continuation of the firm’s atypical ...